Dexamethasone in a small patient population (sever
Post# of 148172
Itolizumab was open label.
“Trust us... the treatment patients were just as sick and the statistical significance kicked ass in the 30 patient trial”
Don’t worry, they are “planning” a double blinded, random assorted placebo controlled study.
Perhaps something like the ones being co ducted here.